Arnold DL, Piani-Meier D, Bar-Or A, Benedict RH, et al. Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial. Mult Scler 2022 Mar 9:13524585221076717. doi: 10.1177/13524585221076717.
PMID: 35261318